Smart inhaler app aims to help people breathe easier

NCT ID NCT03890666

Completed Disease control Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested whether a digital inhaler system—which includes a smart inhaler, a phone app, and a dashboard for doctors—helps people with asthma manage their condition better than a standard inhaler alone. Over 300 participants aged 13 and older with suboptimal asthma control used the system for 12 weeks. The main goal was to see if using the digital tools led to more people achieving meaningful improvement in their asthma control.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Teva Investigational Site 14187

Cincinnati, Ohio, 45231, United States
Teva Investigational Site 14188

San Antonio, Texas, 78207, United States
Teva Investigational Site 14189

San Antonio, Texas, 78251, United States
Teva Investigational Site 14190

Greenfield, Wisconsin, 53228, United States
Teva Investigational Site 14191

Owensboro, Kentucky, 42301, United States
Teva Investigational Site 14192

San Antonio, Texas, 78229, United States
Teva Investigational Site 14195

Savannah, Georgia, 31406, United States
Teva Investigational Site 14196

Greenville, South Carolina, 29607, United States
Teva Investigational Site 14197

Aventura, Florida, 33180, United States
Teva Investigational Site 14198

Denver, Colorado, 80206, United States
Teva Investigational Site 14200

Providence, Rhode Island, 02906, United States
Teva Investigational Site 14207

Bellevue, Nebraska, 68123-4303, United States
Teva Investigational Site 14208

Pittsburgh, Pennsylvania, 15241, United States
Teva Investigational Site 14210

Philadelphia, Pennsylvania, 19140, United States
Teva Investigational Site 14215

Sarasota, Florida, 34239, United States
Teva Investigational Site 14217

Evanston, Illinois, 60201, United States
Teva Investigational Site 14218

Springfield, Illinois, 62704, United States
Teva Investigational Site 14220

New Haven, Connecticut, 06510, United States
Teva Investigational Site 14221

New York, New York, 10461, United States
Teva Investigational Site 14232

Birmingham, Alabama, 35209, United States
Teva Investigational Site 14233

Ann Arbor, Michigan, 48109, United States
Teva Investigational Site 14234

Chapel Hill, North Carolina, 27599, United States
Teva Investigational Site 14236

Colorado Springs, Colorado, 80907, United States
Teva Investigational Site 14300

Charleston, South Carolina, 29407, United States
Teva Investigational Site 14301

Stockton, California, 95207-6204, United States
Teva Investigational Site 14302

Los Angeles, California, 90025, United States
Teva Investigational Site 14304

Albany, Georgia, 31707, United States
Teva Investigational Site 14305

Louisville, Kentucky, 40215, United States
Teva Investigational Site 14306

Miami, Florida, 33186, United States

Conditions

Explore the condition pages connected to this study.

ASTHMA